Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 239

1.

Altered frequencies of Th17 and Treg cells in children and adolescents with obsessive-compulsive disorder.

Rodríguez N, Morer A, González-Navarro EA, Serra-Pages C, Boloc D, Torres T, Martinez-Pinteño A, Mas S, Lafuente A, Gassó P, Lázaro L.

Brain Behav Immun. 2019 Jul 22. pii: S0889-1591(19)30409-X. doi: 10.1016/j.bbi.2019.07.022. [Epub ahead of print]

PMID:
31344493
2.

One decade of the first episodes project (PEPs): Advancing towards a precision psychiatry.

Bernardo M, Cabrera B, Arango C, Bioque M, Castro-Fornieles J, Cuesta MJ, Lafuente A, Parellada M, Saiz-Ruiz J, Vieta E.

Rev Psiquiatr Salud Ment. 2019 Jul - Sep;12(3):135-140. doi: 10.1016/j.rpsm.2019.03.001. Epub 2019 May 16. English, Spanish. No abstract available.

PMID:
31103407
3.

Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis.

Bioque M, Mas S, Costanzo MC, Cabrera B, Lobo A, González-Pinto A, Rodriguez-Toscano E, Corripio I, Vieta E, Baeza I, Ibáñez Á, Fraile MG, Cuesta MJ, Mezquida G, Lafuente A, Bernardo M; PEPs GROUP.

Eur Neuropsychopharmacol. 2019 Jun;29(6):786-794. doi: 10.1016/j.euroneuro.2019.04.005. Epub 2019 May 7.

PMID:
31076188
4.

Author Correction: Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics.

Boloc D, Gortat A, Cheng-Zhang JQ, García-Cerro S, Rodríguez N, Parellada M, Saiz-Ruiz J, Cuesta MJ, Gassó P, Lafuente A, Bernardo M, Mas S.

Transl Psychiatry. 2019 May 2;9(1):145. doi: 10.1038/s41398-019-0480-z.

5.

Genetic variability in the serotoninergic system and age of onset in anorexia nervosa and obsessive-compulsive disorder.

Plana MT, Torres T, Rodríguez N, Boloc D, Gassó P, Moreno E, Lafuente A, Castro-Fornieles J, Mas S, Lazaro L.

Psychiatry Res. 2019 Jan;271:554-558. doi: 10.1016/j.psychres.2018.12.019. Epub 2018 Dec 6.

PMID:
30554102
6.

Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics.

Boloc D, Gortat A, Cheng-Zhang JQ, García-Cerro S, Rodríguez N, Parellada M, Saiz-Ruiz J, Cuesta MJ, Gassó P, Lafuente A, Bernardo M, Mas S.

Transl Psychiatry. 2018 Dec 13;8(1):276. doi: 10.1038/s41398-018-0330-4. Erratum in: Transl Psychiatry. 2019 May 2;9(1):145.

7.

Exploring Genetic Associations of Alzheimer's Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes.

Espinosa A, Hernández-Olasagarre B, Moreno-Grau S, Kleineidam L, Heilmann-Heimbach S, Hernández I, Wolfsgruber S, Wagner H, Rosende-Roca M, Mauleón A, Vargas L, Lafuente A, Rodríguez-Gómez O, Abdelnour C, Gil S, Marquié M, Santos-Santos MA, Sanabria Á, Ortega G, Monté-Rubio G, Pérez A, Ibarria M, Ruiz S, Kornhuber J, Peters O, Frölich L, Hüll M, Wiltfang J, Luck T, Riedel-Heller S, Montrreal L, Cañabate P, Moreno M, Preckler S, Aguilera N, de Rojas I, Orellana A, Alegret M, Valero S, Nöthen MM, Wagner M, Jessen F, Tárraga L, Boada M, Ramírez A, Ruiz A.

Front Aging Neurosci. 2018 Oct 30;10:340. doi: 10.3389/fnagi.2018.00340. eCollection 2018.

8.

Genetic Associations of Serotoninergic and GABAergic Genes in an Extended Collection of Early-Onset Obsessive-Compulsive Disorder Trios.

Boloc D, Mas S, Rodriguez N, Ortiz AE, Morer A, Plana MT, Lafuente A, Lazaro L, Gassó P.

J Child Adolesc Psychopharmacol. 2019 Mar;29(2):152-157. doi: 10.1089/cap.2018.0073. Epub 2018 Oct 23.

PMID:
30351181
9.

Simulated climate change affects how biocrusts modulate water gains and desiccation dynamics after rainfall events.

Lafuente A, Berdugo M, de Guevara ML, Gozalo B, Maestre FT.

Ecohydrology. 2018 Sep;11(6). pii: e1935. doi: 10.1002/eco.1935. Epub 2017 Dec 22.

10.

MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia.

Navinés-Ferrer A, Serrano-Candelas E, Lafuente A, Muñoz-Cano R, Martín M, Gastaminza G.

Sci Rep. 2018 Aug 2;8(1):11628. doi: 10.1038/s41598-018-29965-8.

11.

Further Support for the Involvement of Genetic Variants Related to the Serotonergic Pathway in the Antidepressant Response in Children and Adolescents After a 12-Month Follow-Up: Impact of the HTR2A rs7997012 Polymorphism.

Gassó P, Blázquez A, Rodríguez N, Boloc D, Torres T, Mas S, Lafuente A, Lázaro L.

J Child Adolesc Psychopharmacol. 2018 Jul 5. doi: 10.1089/cap.2018.0004. [Epub ahead of print]

PMID:
29975559
12.

Perfluorooctane sulfonate (PFOS) can alter the hypothalamic-pituitary-adrenal (HPA) axis activity by modifying CRF1 and glucocorticoid receptors.

Salgado-Freiría R, López-Doval S, Lafuente A.

Toxicol Lett. 2018 Oct 1;295:1-9. doi: 10.1016/j.toxlet.2018.05.025. Epub 2018 May 26.

PMID:
29807116
13.

Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis.

Gassó P, Mas S, Bioque M, Cabrera B, Lobo A, González-Pinto A, Díaz-Caneja CM, Corripio I, Vieta E, Castro-Fornieles J, Sarró S, Mané A, Sanjuan J, Llerena A, Lafuente A, Saiz-Ruiz J, Bernardo M; PEPs Group.

J Psychopharmacol. 2018 Jun;32(6):702-710. doi: 10.1177/0269881118773026. Epub 2018 May 16.

PMID:
29767567
14.

Patient Engagement: The Fundació ACE Framework for Improving Recruitment and Retention in Alzheimer's Disease Research.

Boada M, Santos-Santos MA, Rodríguez-Gómez O, Alegret M, Cañabate P, Lafuente A, Abdelnour C, Buendía M, de Dios MJ, Morera A, Sanabria Á, Campo L, Ruiz A, Tárraga L.

J Alzheimers Dis. 2018;62(3):1079-1090. doi: 10.3233/JAD-170866. Review. Erratum in: J Alzheimers Dis. 2018;63(3):1207.

15.

Warming reduces the cover, richness and evenness of lichen-dominated biocrusts but promotes moss growth: insights from an 8 yr experiment.

Ladrón de Guevara M, Gozalo B, Raggio J, Lafuente A, Prieto M, Maestre FT.

New Phytol. 2018 Nov;220(3):811-823. doi: 10.1111/nph.15000. Epub 2018 Jan 30.

PMID:
29380398
16.

Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase I trial.

Lacosta AM, Pascual-Lucas M, Pesini P, Casabona D, Pérez-Grijalba V, Marcos-Campos I, Sarasa L, Canudas J, Badi H, Monleón I, San-José I, Munuera J, Rodríguez-Gómez O, Abdelnour C, Lafuente A, Buendía M, Boada M, Tárraga L, Ruiz A, Sarasa M.

Alzheimers Res Ther. 2018 Jan 29;10(1):12. doi: 10.1186/s13195-018-0340-8.

17.

Improvement of the Elevated Tryptase Criterion to Discriminate IgE- From Non-IgE-Mediated Allergic Reactions.

Gastaminza G, Lafuente A, Goikoetxea MJ, D'Amelio CM, Bernad-Alonso A, Vega O, Martinez-Molina JA, Ferrer M, Nuñez-Cordoba JM.

Anesth Analg. 2018 Aug;127(2):414-419. doi: 10.1213/ANE.0000000000002656. Erratum in: Anesth Analg. 2018 Nov;127(5):e94.

PMID:
29189281
18.

Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results.

Moreno-Grau S, Rodríguez-Gómez O, Sanabria Á, Pérez-Cordón A, Sánchez-Ruiz D, Abdelnour C, Valero S, Hernández I, Rosende-Roca M, Mauleón A, Vargas L, Lafuente A, Gil S, Santos-Santos MÁ, Alegret M, Espinosa A, Ortega G, Guitart M, Gailhajanet A, de Rojas I, Sotolongo-Grau Ó, Ruiz S, Aguilera N, Papasey J, Martín E, Peleja E; Alzheimer's Disease Neuroimaging Initiative, Lomeña F, Campos F, Vivas A, Gómez-Chiari M, Tejero MÁ, Giménez J, Serrano-Ríos M, Orellana A, Tárraga L, Ruiz A, Boada M; FACEHBI study group.

Alzheimers Dement. 2018 May;14(5):634-643. doi: 10.1016/j.jalz.2017.10.005. Epub 2017 Nov 20.

19.

Correction: Integrating Genetic, Neuropsychological and Neuroimaging Data to Model Early-Onset Obsessive Compulsive Disorder Severity.

Mas S, Gassó P, Morer A, Calvo A, Bargalló N, Lafuente A, Lázaro L.

PLoS One. 2017 Oct 11;12(10):e0186572. doi: 10.1371/journal.pone.0186572. eCollection 2017.

20.

SiNoPsis: Single Nucleotide Polymorphisms selection and promoter profiling.

Boloc D, Rodríguez N, Gassó P, Abril JF, Bernardo M, Lafuente A, Mas S.

Bioinformatics. 2017 Sep 14. doi: 10.1093/bioinformatics/btx570. [Epub ahead of print]

PMID:
28968821
21.

Microarray gene-expression study in fibroblast and lymphoblastoid cell lines from antipsychotic-naïve first-episode schizophrenia patients.

Gassó P, Mas S, Rodríguez N, Boloc D, García-Cerro S, Bernardo M, Lafuente A, Parellada E.

J Psychiatr Res. 2017 Dec;95:91-101. doi: 10.1016/j.jpsychires.2017.08.003. Epub 2017 Aug 5.

PMID:
28822801
22.

Routing in Mobile Wireless Sensor Networks: A Leader-Based Approach.

Burgos U, Amozarrain U, Gómez-Calzado C, Lafuente A.

Sensors (Basel). 2017 Jul 7;17(7). pii: E1587. doi: 10.3390/s17071587.

23.

Human-leukocyte antigen class II genes in early-onset obsessive-compulsive disorder.

Rodriguez N, Morer A, González-Navarro EA, Gassó P, Boloc D, Serra-Pagès C, Lafuente A, Lazaro L, Mas S.

World J Biol Psychiatry. 2019 Jun;20(5):352-358. doi: 10.1080/15622975.2017.1327669. Epub 2017 May 31.

PMID:
28562177
24.

Association of regulatory TPH2 polymorphisms with higher reduction in depressive symptoms in children and adolescents treated with fluoxetine.

Gassó P, Rodríguez N, Boloc D, Blázquez A, Torres T, Gortat A, Plana MT, Lafuente A, Mas S, Arnaiz JA, Lázaro L.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jul 3;77:236-240. doi: 10.1016/j.pnpbp.2017.04.031. Epub 2017 Apr 26.

PMID:
28456685
25.

Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients.

Mas S, Gassó P, Torra M, Bioque M, Lobo A, González-Pinto A, Olmeda MS, Corripio I, Vieta E, Castro-Fornieles J, Rodriguez-Jimenez R, Bobes J, Usall J, Llerena A, Saiz-Ruiz J, Bernardo M, Lafuente A, PEPs Group.

Eur Neuropsychopharmacol. 2017 Jul;27(7):647-656. doi: 10.1016/j.euroneuro.2017.03.012. Epub 2017 Apr 5.

PMID:
28389049
26.

Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.

Espinosa A, Alegret M, Pesini P, Valero S, Lafuente A, Buendía M, San José I, Ibarria M, Tejero MA, Giménez J, Ruiz S, Hernández I, Pujadas F, Martínez-Lage P, Munuera J, Arbizu J, Tárraga L, Hendrix SB, Ruiz A, Becker JT, Landau SM, Sotolongo-Grau O, Sarasa M, Boada M; AB255 Study Group; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2017;57(2):447-459. doi: 10.3233/JAD-161223.

27.

Epigenetic and genetic variants in the HTR1B gene and clinical improvement in children and adolescents treated with fluoxetine.

Gassó P, Rodríguez N, Blázquez A, Monteagudo A, Boloc D, Plana MT, Lafuente A, Lázaro L, Arnaiz JA, Mas S.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Apr 3;75:28-34. doi: 10.1016/j.pnpbp.2016.12.003. Epub 2016 Dec 23.

PMID:
28025020
28.

Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer's Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial.

Boada M, Anaya F, Ortiz P, Olazarán J, Shua-Haim JR, Obisesan TO, Hernández I, Muñoz J, Buendia M, Alegret M, Lafuente A, Tárraga L, Núñez L, Torres M, Grifols JR, Ferrer I, Lopez OL, Páez A.

J Alzheimers Dis. 2017;56(1):129-143. doi: 10.3233/JAD-160565.

29.

Pharmacogenetic study focused on fluoxetine pharmacodynamics in children and adolescent patients: impact of the serotonin pathway.

Mas S, Blázquez A, Rodríguez N, Boloc D, Lafuente A, Arnaiz JA, Lázaro L, Gassó P.

Pharmacogenet Genomics. 2016 Nov;26(11):487-496.

PMID:
27660918
30.

Association of CACNA1C and SYNE1 in offspring of patients with psychiatric disorders.

Gassó P, Sánchez-Gistau V, Mas S, Sugranyes G, Rodríguez N, Boloc D, de la Serna E, Romero S, Moreno D, Moreno C, Díaz-Caneja CM, Lafuente A, Castro-Fornieles J.

Psychiatry Res. 2016 Nov 30;245:427-435. doi: 10.1016/j.psychres.2016.08.058. Epub 2016 Sep 2.

PMID:
27620326
31.

One-Year Follow-up of Children and Adolescents with Major Depressive Disorder: Relationship between Clinical Variables and Abcb1 Gene Polymorphisms.

Blázquez A, Gassó P, Mas S, Plana MT, Lafuente A, Lázaro L.

Pharmacopsychiatry. 2016 Nov;49(6):248-253. doi: 10.1055/s-0042-108202. Epub 2016 Jun 16.

PMID:
27309038
32.

Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes.

Mas S, Gassó P, Lafuente A, Bioque M, Lobo A, Gonzàlez-Pinto A, Olmeda MS, Corripio I, Llerena A, Cabrera B, Saiz-Ruiz J, Bernardo M; PEPs GROUP.

Pharmacogenomics J. 2016 Oct;16(5):439-45. doi: 10.1038/tpj.2016.44. Epub 2016 Jun 7.

PMID:
27272046
33.

The expression of several reproductive hormone receptors can be modified by perfluorooctane sulfonate (PFOS) in adult male rats.

López-Doval S, Salgado R, Lafuente A.

Chemosphere. 2016 Jul;155:488-497. doi: 10.1016/j.chemosphere.2016.04.081. Epub 2016 May 2.

PMID:
27151425
34.

Integrating Genetic, Neuropsychological and Neuroimaging Data to Model Early-Onset Obsessive Compulsive Disorder Severity.

Mas S, Gassó P, Morer A, Calvo A, Bargalló N, Lafuente A, Lázaro L.

PLoS One. 2016 Apr 19;11(4):e0153846. doi: 10.1371/journal.pone.0153846. eCollection 2016. Erratum in: PLoS One. 2017 Oct 11;12 (10 ):e0186572.

35.

Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia.

García-Bueno B, Gassó P, MacDowell KS, Callado LF, Mas S, Bernardo M, Lafuente A, Meana JJ, Leza JC.

J Psychiatry Neurosci. 2016 Apr;41(3):E46-55.

36.

Impact of vineyard abandonment and natural recolonization on metal content and availability in Mediterranean soils.

de Santiago-Martín A, Vaquero-Perea C, Valverde-Asenjo I, Quintana Nieto JR, González-Huecas C, Lafuente AL, Vázquez de la Cueva A.

Sci Total Environ. 2016 May 1;551-552:57-65. doi: 10.1016/j.scitotenv.2016.01.185. Epub 2016 Feb 11.

PMID:
26874761
37.

Applicability of gene expression and systems biology to develop pharmacogenetic predictors; antipsychotic-induced extrapyramidal symptoms as an example.

Mas S, Gassó P, Lafuente A.

Pharmacogenomics. 2015 Nov;16(17):1975-88. doi: 10.2217/pgs.15.134. Epub 2015 Nov 10. Review.

PMID:
26556470
38.

Perfluorooctane sulfonate (PFOS) exposure could modify the dopaminergic system in several limbic brain regions.

Salgado R, López-Doval S, Pereiro N, Lafuente A.

Toxicol Lett. 2016 Jan 5;240(1):226-35. doi: 10.1016/j.toxlet.2015.10.023. Epub 2015 Oct 31.

PMID:
26529483
39.

A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project.

Bioque M, Llerena A, Cabrera B, Mezquida G, Lobo A, González-Pinto A, Díaz-Caneja CM, Corripio I, Aguilar EJ, Bulbena A, Castro-Fornieles J, Vieta E, Lafuente A, Mas S, Parellada M, Saiz-Ruiz J, Cuesta MJ, Bernardo M; PEPs GROUP.

Int J Neuropsychopharmacol. 2016 Mar 31;19(4). pii: pyv121. doi: 10.1093/ijnp/pyv121. Print 2016 Apr.

40.

Association between genetic variants of serotonergic and glutamatergic pathways and the concentration of neurometabolites of the anterior cingulate cortex in paediatric patients with obsessive-compulsive disorder.

Ortiz AE, Gassó P, Mas S, Falcon C, Bargalló N, Lafuente A, Lázaro L.

World J Biol Psychiatry. 2016 Aug;17(5):394-404. doi: 10.3109/15622975.2015.1111524. Epub 2015 Dec 14.

PMID:
26505676
41.

Apoptotic markers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls.

Batalla A, Bargalló N, Gassó P, Molina O, Pareto D, Mas S, Roca JM, Bernardo M, Lafuente A, Parellada E.

Transl Psychiatry. 2015 Aug 25;5:e626. doi: 10.1038/tp.2015.122.

42.

Association between genetic variants related to glutamatergic, dopaminergic and neurodevelopment pathways and white matter microstructure in child and adolescent patients with obsessive-compulsive disorder.

Gassó P, Ortiz AE, Mas S, Morer A, Calvo A, Bargalló N, Lafuente A, Lázaro L.

J Affect Disord. 2015 Nov 1;186:284-92. doi: 10.1016/j.jad.2015.07.035. Epub 2015 Jul 30.

PMID:
26254621
43.

Network analysis of gene expression in mice provides new evidence of involvement of the mTOR pathway in antipsychotic-induced extrapyramidal symptoms.

Mas S, Gassó P, Boloc D, Rodriguez N, Mármol F, Sánchez J, Bernardo M, Lafuente A.

Pharmacogenomics J. 2016 Jun;16(3):293-300. doi: 10.1038/tpj.2015.48. Epub 2015 Jun 30.

PMID:
26122020
44.

Initial study on the possible mechanisms involved in the effects of high doses of perfluorooctane sulfonate (PFOS) on prolactin secretion.

Salgado R, Pereiro N, López-Doval S, Lafuente A.

Food Chem Toxicol. 2015 Sep;83:10-6. doi: 10.1016/j.fct.2015.05.013. Epub 2015 May 30.

PMID:
26032630
45.

The incidence of perioperative hypersensitivity reactions: a single-center, prospective, cohort study.

Berroa F, Lafuente A, Javaloyes G, Cabrera-Freitag P, de la Borbolla JM, Moncada R, Goikoetxea MJ, Sanz ML, Ferrer M, Gastaminza G.

Anesth Analg. 2015 Jul;121(1):117-23. doi: 10.1213/ANE.0000000000000776.

PMID:
25902325
46.

Network analysis of gene expression in peripheral blood identifies mTOR and NF-κB pathways involved in antipsychotic-induced extrapyramidal symptoms.

Mas S, Gassó P, Parellada E, Bernardo M, Lafuente A.

Pharmacogenomics J. 2015 Oct;15(5):452-60. doi: 10.1038/tpj.2014.84. Epub 2015 Jan 27.

PMID:
25623440
47.

Possible role of serotonin and neuropeptide Y on the disruption of the reproductive axis activity by perfluorooctane sulfonate.

López-Doval S, Salgado R, Fernández-Pérez B, Lafuente A.

Toxicol Lett. 2015 Mar 4;233(2):138-47. doi: 10.1016/j.toxlet.2015.01.012. Epub 2015 Jan 23.

PMID:
25623392
48.

Pharmacogenetic predictor of extrapyramidal symptoms induced by antipsychotics: multilocus interaction in the mTOR pathway.

Mas S, Gassó P, Ritter MA, Malagelada C, Bernardo M, Lafuente A.

Eur Neuropsychopharmacol. 2015 Jan;25(1):51-9. doi: 10.1016/j.euroneuro.2014.11.011. Epub 2014 Nov 29.

PMID:
25499605
49.

Association between cell-bound blood amyloid-β(1-40) levels and hippocampus volume.

Sotolongo-Grau O, Pesini P, Valero S, Lafuente A, Buendía M, Pérez-Grijalba V, José IS, Ibarria M, Tejero MA, Giménez J, Hernández I, Tárraga L, Ruiz A, Boada M, Sarasa M.

Alzheimers Res Ther. 2014 Oct 20;6(5-8):56. doi: 10.1186/s13195-014-0056-3. eCollection 2014.

50.

The peroneocuboid joint: morphogenesis and anatomical study.

Guimerá V, Lafuente A, Zambrana L, Rodriguez-Niedenführ M, Sañudo JR, Vazquez T.

J Anat. 2015 Jan;226(1):104-12. doi: 10.1111/joa.12249. Epub 2014 Nov 10.

Supplemental Content

Loading ...
Support Center